Systemic Vasculitis in Adolescence and Young Adulthood

  • Hafize Emine Sönmez
  • Yelda Bilginer
  • Seza Özen
Part of the In Clinical Practice book series (ICP)


Primary systemic vasculitides of adolescents and young adults AYA are relatively rare diseases, but may be associated with significant morbidity and mortality. We provide an overview of systemic vasculitides and emphasise the problems to be anticipated in adolescence and young adulthood.


Systemic vasculitides Adolescent Young adult ANCA-associated vasculitis Classification criteria 


  1. 1.
    Eleftheriou D, Batu ED, Ozen S, Brogan PA. Vasculitis in children. Nephrol Dial Transpl Off Publ Eur Dial Transpl Assoc Eur Renal Assoc. 2015;30(Suppl 1):i94–103.Google Scholar
  2. 2.
    Donaldson L, Banatvala N. Health is global: proposals for a UK Government-wide strategy. Lancet. 2007;369(9564):857–61.CrossRefGoogle Scholar
  3. 3.
    Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11.CrossRefGoogle Scholar
  4. 4.
    Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69(5):798–806.CrossRefGoogle Scholar
  5. 5.
    Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, et al. EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: overall methodology and clinical characterisation. Ann Rheum Dis. 2010;69(5):790–7.CrossRefGoogle Scholar
  6. 6.
    Bohm M, Gonzalez Fernandez MI, Ozen S, Pistorio A, Dolezalova P, Brogan P, et al. Clinical features of childhood granulomatosis with polyangiitis (wegener’s granulomatosis). Pediatr Rheumatol Online J. 2014;12:18.CrossRefGoogle Scholar
  7. 7.
    Iudici M, Quartier P, Terrier B, Mouthon L, Guillevin L, Puechal X. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: systematic review and meta-analysis. Orphanet J Rare Dis. 2016;11(1):141.CrossRefGoogle Scholar
  8. 8.
    Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094–100.CrossRefGoogle Scholar
  9. 9.
    Zwerina J, Eger G, Englbrecht M, Manger B, Schett G. Churg-Strauss syndrome in childhood: a systematic literature review and clinical comparison with adult patients. Semin Arthritis Rheum. 2009;39(2):108–15.CrossRefGoogle Scholar
  10. 10.
    Yates M, Watts RA, Bajema IM, Cid MC, Crestani B, Hauser T, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75(9):1583–94.CrossRefGoogle Scholar
  11. 11.
    Eleftheriou D, Dillon MJ, Tullus K, Marks SD, Pilkington CA, Roebuck DJ, et al. Systemic polyarteritis nodosa in the young: a single-center experience over thirty-two years. Arthritis Rheum. 2013;65(9):2476–85.CrossRefGoogle Scholar
  12. 12.
    Ozen S, Bakkaloglu A, Dusunsel R, Soylemezoglu O, Ozaltin F, Poyrazoglu H, et al. Childhood vasculitides in Turkey: a nationwide survey. Clin Rheumatol. 2007;26(2):196–200.PubMedGoogle Scholar
  13. 13.
    Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, et al. Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatr. 2004;145(4):517–22.CrossRefGoogle Scholar
  14. 14.
    Ozcakar ZB, Yalcinkaya F, Fitoz S, Yuksel S, Acar B, Caltik A, et al. Polyarteritis nodosa: successful diagnostic imaging utilizing pulsed and color Doppler ultrasonography and computed tomography angiography. Eur J Pediatr. 2006;165(2):120–3.CrossRefGoogle Scholar
  15. 15.
    Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, et al. EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis. 2009;68(3):310–7.CrossRefGoogle Scholar
  16. 16.
    McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term Management of Kawasaki Disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927–e99.CrossRefGoogle Scholar
  17. 17.
    Eleftheriou D, Varnier G, Dolezalova P, McMahon AM, Al-Obaidi M, Brogan PA. Takayasu arteritis in childhood: retrospective experience from a tertiary referral Centre in the United Kingdom. Arthritis Res Ther. 2015;17:36.CrossRefGoogle Scholar
  18. 18.
    Ozen S, Duzova A, Bakkaloglu A, Bilginer Y, Cil BE, Demircin M, et al. Takayasu arteritis in children: preliminary experience with cyclophosphamide induction and corticosteroids followed by methotrexate. J Pediatr. 2007;150(1):72–6.CrossRefGoogle Scholar
  19. 19.
    Keser G, Aksu K. What is new in management of Takayasu arteritis? Presse Med. 2017;46(7–8 Pt 2):e229–e35.CrossRefGoogle Scholar
  20. 20.
    Sarica R, Azizlerli G, Kose A, Disci R, Ovul C, Kural Z. Juvenile Behcet’s disease among 1784 Turkish Behcet’s patients. Int J Dermatol. 1996;35(2):109–11.CrossRefGoogle Scholar
  21. 21.
    Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behcet’s disease in Germany and in Europe. Yonsei Med J. 1997;38(6):411–22.CrossRefGoogle Scholar
  22. 22.
    Kone-Paut I, Shahram F, Darce-Bello M, Cantarini L, Cimaz R, Gattorno M, et al. Consensus classification criteria for paediatric Behcet’s disease from a prospective observational cohort: PEDBD. Ann Rheum Dis. 2016;75(6):958–64.CrossRefGoogle Scholar
  23. 23.
    Ozen S, Eroglu FK. Pediatric-onset Behcet disease. Curr Opin Rheumatol. 2013;25(5):636–42.CrossRefGoogle Scholar
  24. 24.
    Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behcet disease. Ann Rheum Dis. 2008;67(12):1656–62.CrossRefGoogle Scholar
  25. 25.
    Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.PubMedPubMedCentralGoogle Scholar
  26. 26.
    Miller JJ 3rd, Williams GF, Leissring JC. Multiple late complications of therapy with cyclophosphamide, including ovarian destruction. Am J Med. 1971;50(4):530–5.CrossRefGoogle Scholar
  27. 27.
    Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC, et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Women’s Health. 2009;18(3):311–9.CrossRefGoogle Scholar
  28. 28.
    Machen L, Clowse ME. Vasculitis and pregnancy. Rheum Dis Clin N Am. 2017;43(2):239–47.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Hafize Emine Sönmez
    • 1
  • Yelda Bilginer
    • 1
  • Seza Özen
    • 2
  1. 1.Department of Pediatric RheumatologyHacettepe University Faculty of MedicineAnkaraTurkey
  2. 2.Department of Pediatrics, Division of RheumatologyHacettepe University Faculty of MedicineAnkaraTurkey

Personalised recommendations